SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China's Affluent Consumer Market

SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China's Affluent Consumer Market

NEW YORK, March 3, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services in China, today announced its selection as the exclusive...

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- On 21 February, Guo Guangchang, Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025, stating that private enterprises are not afraid of competition as...

Regal Hotels Leverages Network to Support Hong Kong's Healthcare Professionals with an Exclusive Long-stay Accommodation Programme

Regal Hotels Leverages Network to Support Hong Kong's Healthcare Professionals with an Exclusive Long-stay Accommodation Programme

HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Regal Hotels International is leveraging its extensive hotel network to launch the exclusive "Long-stay Accommodation Programme" for Hospital Authority (HA) staff. In response to the increasing demand for...

JX Luxventure Group Unveils 'LuxGent': A DeepSeek type Proprietary AI Chat Agent

JX Luxventure Group Unveils 'LuxGent': A DeepSeek type Proprietary AI Chat Agent

HAIKOU, China, Feb. 12, 2025 /PRNewswire/ -- JX Luxventure Group Inc. (Nasdaq: JXG) (the "Company"), a company in the wholesale trade sector specializing in duty-free and cross-border consumer goods, as well as providing integrated solutions in...

AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application

AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application

HONG KONG, Feb. 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for...

YQN at CES 2025: Redefining Smart Logistics for Global Trade

YQN at CES 2025: Redefining Smart Logistics for Global Trade

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- The globally renowned CES, widely recognized as a barometer of consumer electronics and technology trends, recently opened in Las Vegas, USA, attracting technology giants, business leaders, and media from...

  • 1
  • 2
  • 3
  • menu
    menu